doi: 10.1056/NEJMsb050564.
Medicare and cost-effectiveness analysis
Affiliations
- PMID: 16207857
- DOI: 10.1056/NEJMsb050564
Item in Clipboard
Medicare and cost-effectiveness analysis
N Engl J Med.
.
No abstract available
Comment in
-
Medicare and cost-effectiveness analysis.N Engl J Med. 2006 Jan 12;354(2):207-9; author reply 207-9. doi: 10.1056/NEJMc052992. N Engl J Med. 2006. PMID: 16407521 No abstract available.
-
Medicare and cost-effectiveness analysis.N Engl J Med. 2006 Jan 12;354(2):207-9; author reply 207-9. N Engl J Med. 2006. PMID: 16411303 No abstract available.
-
Medicare and cost-effectiveness analysis.N Engl J Med. 2006 Jan 12;354(2):207-9; author reply 207-9. N Engl J Med. 2006. PMID: 16411304 No abstract available.
Similar articles
-
The limited regulatory potential of medical technology assessment.Va Law Rev. 1996 Nov;82(8):1525-1622. Va Law Rev. 1996. PMID: 16715565 No abstract available.
-
Are the additional health expenditures generated by insurance bad for society?Minn Med. 2004 Feb;87(2):56-9. Minn Med. 2004. PMID: 15005130
-
The cost implications of health care reform.N Engl J Med. 2010 Jun 3;362(22):2050-1. doi: 10.1056/NEJMp1005117. Epub 2010 May 12. N Engl J Med. 2010. PMID: 20463330 No abstract available.
-
Challenges ahead for federal technology assessment.Health Aff (Millwood). 2007 Mar-Apr;26(2):w150-2. doi: 10.1377/hlthaff.26.2.w150. Epub 2007 Jan 26. Health Aff (Millwood). 2007. PMID: 17259197 Review.
-
A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008. J Am Coll Radiol. 2008. PMID: 18954812 Review.
Cited by
-
The ethics and reality of rationing in medicine.Chest. 2011 Dec;140(6):1625-1632. doi: 10.1378/chest.11-0622. Chest. 2011. PMID: 22147821 Free PMC article. Review.
-
Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany.J Cardiovasc Magn Reson. 2013 Apr 10;15(1):30. doi: 10.1186/1532-429X-15-30. J Cardiovasc Magn Reson. 2013. PMID: 23574690 Free PMC article.
-
Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?Clin Drug Investig. 2020 Dec;40(12):1107-1113. doi: 10.1007/s40261-020-00972-w. Epub 2020 Oct 9. Clin Drug Investig. 2020. PMID: 33037566 Free PMC article. Review.
-
Cost-effectiveness modeling research of pharmacologic therapy to prevent osteoporosis-related fractures.Curr Rheumatol Rep. 2007 Apr;9(1):50-6. doi: 10.1007/s11926-007-0022-1. Curr Rheumatol Rep. 2007. PMID: 17437668 Review.
-
A new method for examining the cost savings of reducing COPD exacerbations.Pharmacoeconomics. 2010;28(9):733-49. doi: 10.2165/11535600-000000000-00000. Pharmacoeconomics. 2010. PMID: 20799755
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
